Online Testosterone Prescription 2026: Is It Legal, and How Does It Actually Work?

Last updated: May 20, 2026 · Medically reviewed by Dr. Marcus Tan, MD · ~10 min read

DEA Schedule III + the Fourth Temporary Extension explained

Testosterone has been a federally controlled substance since the Anabolic Steroid Control Act of 1990 classified anabolic steroids as Schedule III. Schedule III means a substance has accepted medical use but a moderate potential for dependence and abuse. The practical consequence: a federal DEA registration is required for any clinician who prescribes it, and an in-person evaluation has historically been required under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008.

That requirement was waived during the COVID-19 public health emergency in March 2020. When the public health emergency ended, the DEA issued a series of temporary extensions rather than letting telehealth prescribing snap back to pre-pandemic rules:

• First Temporary Extension — May 2023
• Second Temporary Extension — October 2023, through end of 2024
• Third Temporary Extension — November 2024, through end of 2025
• Fourth Temporary Extension — issued December 19, 2025, effective January 1, 2026 through December 31, 2026

Each extension lets practitioners “initiate and continue” prescribing of Schedule II–V controlled substances by telemedicine, provided they comply with the law of the state where the patient is physically located when the consult happens. Testosterone falls squarely inside that window.

What the January 1 – December 31, 2026 rule allows (and what it doesn’t)

The Fourth Temporary Extension allows a licensed practitioner to:

• Conduct the entire initial evaluation by audio-video telehealth.
• Prescribe testosterone cypionate, enanthate, undecanoate, topical cream, gel, or troches without an in-person visit.
• Continue refills indefinitely while the patient remains under their care, provided ongoing safety monitoring is documented.

It does not override state medical board rules. A handful of states — Alabama, Arkansas, Indiana, and West Virginia have historically been the strictest — layer additional in-person or supervisory requirements on top of the federal floor. Reputable national clinics maintain a state-by-state prescribing matrix and will decline to prescribe if your state requires an in-person visit they cannot deliver remotely.

[provider=”hone-health”]

Step-by-step: how to get an online testosterone prescription in 2026

Every legitimate online TRT clinic follows roughly the same five-step intake. If a clinic skips one of these, walk away.

Step 1 — Symptom screen and medical history (free, ~10 minutes)

You complete an online questionnaire covering libido, energy, mood, sleep, body composition, cardiovascular history, prostate history, fertility plans, current medications, and family history. Clinics use validated instruments like the ADAM (Androgen Deficiency in the Aging Male) questionnaire to standardize this step.

Step 2 — Diagnostic lab order ($45–$199 depending on clinic)

You receive a lab requisition for a morning blood draw at Quest Diagnostics or LabCorp. A complete TRT baseline panel includes:

• Total testosterone (drawn before 10 a.m.)
• Free testosterone (calculated or direct)
• Sex hormone–binding globulin (SHBG)
• Estradiol (sensitive assay)
• LH and FSH
• Hematocrit and hemoglobin
• Lipid panel
• PSA (prostate-specific antigen) for men ≥40
• Comprehensive metabolic panel
• Thyroid (TSH) — to rule out alternative causes of fatigue

You’ll typically be asked to repeat the testosterone draw on a separate morning. Both AUA 2024 and the Endocrine Society require two confirmatory total testosterone readings below the reference range (commonly <300 ng/dL) before diagnosing hypogonadism.

Step 3 — Physician consult (telehealth video, 20–40 minutes)

An MD or DO reviews your labs, history, and symptoms. They confirm or rule out hypogonadism, classify it as primary (testicular failure) or secondary (pituitary/hypothalamic), and discuss treatment options — including non-TRT options for men who want to preserve fertility.

Step 4 — Prescription transmitted to pharmacy

If TRT is appropriate, the clinician transmits the prescription to either the clinic’s compounding pharmacy partner or a retail pharmacy of your choice. Testosterone cypionate injectable typically arrives within 5–7 business days.

Step 5 — Ongoing monitoring

Repeat labs at month 3, month 6, and then every 6–12 months thereafter. Dose adjustments happen by message or follow-up video. This is non-negotiable for safety.

[provider=”defy-medical”]

Required labs before any reputable clinic will prescribe

If a clinic offers to prescribe testosterone without bloodwork, it is operating outside the standard of care. Period. The labs aren’t optional gatekeeping — they exist because TRT can cause measurable harm in the wrong patient.

The minimum panel above produces the data needed to:

• Confirm hypogonadism — without two low morning T readings, you do not have a clinical diagnosis.
• Establish baseline hematocrit — TRT can drive red blood cell production into erythrocytosis territory. Therapy must be held if hematocrit exceeds 54%.
• Baseline PSA — for prostate cancer screening before introducing an androgen. AUA 2024 requires this for all men ≥40 starting TRT, and a rise of >1.4 ng/mL within 12 months triggers urology referral.
• Baseline LH/FSH — distinguishes primary from secondary hypogonadism, which changes the treatment conversation (especially for men who want fertility-preserving options like enclomiphene).
• Baseline lipids — TRT can reduce HDL cholesterol.

Symptoms + diagnostic criteria the clinic must document

Two low T readings alone do not equal a TRT prescription. The Endocrine Society and AUA both require documented symptoms consistent with androgen deficiency. The clinic chart should note specific complaints — reduced libido, fatigue, depressed mood, loss of morning erections, reduced muscle mass, increased adiposity, or impaired concentration. A telehealth chart that documents low T plus matching symptoms is defensible; one that documents only low T from a single draw is not.

State-by-state nuance (medical board prescribing rules)

Federal DEA rules set the floor. State medical boards set additional rules on top. As of May 2026, the states most likely to add friction are:

• Alabama — historically requires an in-person physician relationship for certain controlled-substance prescribing.
• Arkansas — bona fide patient–physician relationship rules interpreted strictly.
• Indiana — additional documentation requirements for Schedule III telehealth.
• West Virginia — restrictive telehealth controlled-substance rules.

National clinics maintain a real-time state matrix; if your state is excluded, you’ll see a message at intake. Always confirm at the clinic’s licensure page before paying for a kit.

Which online clinics actually hold the prescribing license you need

Four nationally licensed clinics meet the standard described above as of May 2026:

• Hone Health — 50-state license, $149/mo Premium membership + ~$28/mo testosterone cypionate. Quest and LabCorp lab partnerships. Best UX in the DTC space. See our original Hone Health brand review.
• Maximus Tribe — defaults to enclomiphene + pregnenolone (HPT-axis stimulation) for fertility preservation. $99–$199/mo. Traditional TRT track available if enclomiphene fails. See our original Maximus Tribe brand review.
• Defy Medical — Tampa-based concierge clinic, nationwide telehealth. Initial consult $149, all-in monthly $200–$350. Strongest peptide and women’s HRT depth.
• Marek Health — optimization-leaning, $250 intake (one-time annual platform access), ~$225/mo medication. Influencer-driven audience but legitimate physician oversight.

[provider=”maximus-tribe”]

What happens in 2027? The proposed permanent rule

The DEA has signaled in its Fourth Temporary Extension filing that it intends to finalize a permanent telemedicine rule before December 31, 2026. The proposed framework, first floated in 2023, would create a “Special Registration” pathway allowing some practitioners to continue telehealth prescribing of controlled substances without an in-person visit, while requiring others (especially for Schedule II) to conduct at least one in-person evaluation per year.

What that means for testosterone (Schedule III) in 2027: the most likely outcome is that telehealth-initiated TRT remains legal under a Special Registration framework, possibly with a periodic in-person check-in requirement every 12 or 24 months. The least likely outcome is a full revert to pre-2020 rules, which would force tens of thousands of telehealth patients into in-person evaluations overnight — a political and clinical non-starter. Until the final rule lands, the safest assumption is: telehealth TRT is legal through Dec 31, 2026; after that, watch the Federal Register.

Red flags: clinics that prescribe without bloodwork

Avoid any service that:

• Offers testosterone without requiring a Quest or LabCorp blood draw.
• Skips the PSA requirement for men ≥40.
• Does not require a second confirmatory T reading.
• Promises “instant approval” or “same-day prescription.”
• Sells via overseas pharmacies or unmarked vials.
• Does not require ongoing labs at month 3 and beyond.

These patterns indicate the operation is not following AUA or Endocrine Society standards and may not be a legitimate DEA-registered prescriber. The legal pathway exists in 2026 — there is no reason to gamble on a grey-market source.

Renewals, refills, and continuity of care

A Schedule III prescription can be refilled up to five times within six months of issuance under federal law. In practice, reputable online TRT clinics issue 30- to 90-day prescriptions and reauthorize after each lab check. You’ll typically have:

• Month 3: first follow-up labs (total T, free T, hematocrit, estradiol) + dose adjustment if needed.
• Month 6: repeat labs + PSA recheck.
• Year 1+: labs every 6–12 months, with annual PSA and digital rectal exam coordinated locally.

If you move states, the clinic must be licensed in your new state to continue prescribing. Continuity is one of the strongest arguments for picking a 50-state-licensed provider from the start.

Frequently asked questions

Related reading on BestMedsHub

• Testosterone telehealth hub — our overview of the entire vertical.
• Best online TRT clinics for 2026 — six-clinic ranked comparison.
• TRT cost in 2026 — DTC, concierge, and insurance-billed math.
• TRT side effects and monitoring — full YMYL deep-dive.
• Hone Health brand review
• Maximus Tribe brand review

Sources

• U.S. Drug Enforcement Administration. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for the Prescribing of Controlled Medications, Federal Register, December 19, 2025.
• U.S. Department of Health and Human Services. Joint announcement on Schedule II–V telemedicine prescribing, December 2025.
• American Urological Association. Testosterone Deficiency Guideline — 2024 Amendment.
• Bhasin S. et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018 (current).
• U.S. FDA. Testosterone cypionate prescribing information (current revision).
• Lincoff AM et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). NEJM, 2023.
• Ryan Haight Online Pharmacy Consumer Protection Act of 2008, 21 U.S.C. § 829(e).
• Anabolic Steroid Control Act of 1990, Pub. L. 101-647.